Prostaglandin EP4 antagonists. - Wikidata - awgldk - TriplyDB

Prostaglandin EP4 antagonists.

Prostaglandin EP4 antagonists.

http://www.wikidata.org/entity/Q38162977

about

Selective EP4 Antagonist May Be Useful in Treating Arthritis and Arthritic Pain

P2860

Q39786987-EC657B72-1AEA-4306-8358-94D367581057

P2860

Prostaglandin EP4 antagonists.

http://www.wikidata.org/entity/Q38162977

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Prostaglandin EP4 antagonists.

@en

type

label

Prostaglandin EP4 antagonists.

@en

prefLabel

Prostaglandin EP4 antagonists.

@en

P1433

Q38162977-3C5B6610-A94C-4D7F-BFFF-DE8B862D85B1

P1476

Q38162977-BDC5144D-311A-4D25-9C28-9F3209AEB13D

P2093

Q38162977-63F2C7F3-D940-493E-AADA-AB926C5E547D

Q38162977-E233F4ED-A08C-4E12-AAF8-096E265C6453

P2860

Q38162977-09E8C230-6580-4929-87D9-C26C90ACA3DE

Q38162977-14343C4D-5862-4D3B-B667-67BE2C827941

Q38162977-17676D98-C92E-4982-B213-803B3270D7AB

Q38162977-2B5EFFD8-40B0-4449-BC71-85179219AF4B

Q38162977-2D2B5AA2-5D15-4E8A-9B23-AF1DBA8F8721

Q38162977-4B138FA4-57B4-49DA-8436-3D44B275E884

Q38162977-61F31365-4ECA-4C89-B7D3-F66A4EC823E6

Q38162977-62C5B281-93DC-4772-B449-7B227D088467

Q38162977-6C24A38B-318C-4B34-A4F9-0D0C5FBEA871

Q38162977-72983766-6227-4FAC-8B46-E12115F3BBAC

P304

Q38162977-F7513652-A5B6-4182-A3C4-03BB77DBAA29

P31

Q38162977-6F620818-7E4C-443E-8BCE-CAFDD4AA35FD

P356

Q38162977-3FB2AB6E-4B68-4734-8805-31FE2A4778B3

P433

Q38162977-67A0ABFB-FAFC-4075-A035-62A2EE12D514

P478

Q38162977-46460A38-E7F8-4D9A-ABDB-EB3CEA3105BC

P577

Q38162977-D371AB31-AD63-42B0-89F2-0A63F1634D32

P698

Q38162977-92464E82-92F7-4770-AAA4-357F0A1D7032

P356

P1433

Pharmaceutical patent analyst

P1476

Prostaglandin EP4 antagonists.

@en

P2093

Luigi Piero Stasi

http://www.w3.org/2001/XMLSchema#string

Manuela Borriello

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

Effect of (S)-4-(1-(5-chloro-2-(4-fluorophenyoxy)benzamido)ethyl) benzoic acid (CJ-42794), a selective antagonist of prostaglandin E receptor subtype 4, on ulcerogenic and healing responses in rat gastrointestinal mucosa

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances.

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.

The development of COX2 inhibitors.

Deletion of EP4 on bone marrow-derived cells enhances inflammation and angiotensin II-induced abdominal aortic aneurysm formation.

The pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the prostaglandin E2 human model of headache.

BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache.

P304

387-397

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/PPA.13.15

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24237064

http://www.w3.org/2001/XMLSchema#string